Live Breaking News & Updates on உலகளாவிய விரிவாக்கம் ஆஃப் உயர் வாழ்க்கை தொழில்நுட்பம்

Stay updated with breaking news from உலகளாவிய விரிவாக்கம் ஆஃப் உயர் வாழ்க்கை தொழில்நுட்பம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China


Published: Dec 21, 2020
Collaboration Strengthens Peijia s Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife s Technology
SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/
Peijia Medical Ltd (HK Stock Code: 09996) and
HighLife SAS, a Paris-based medical device company, focused on the development of a unique transeptal mitral valve replacement ( TMVR ) system to treat patients suffering from mitral regurgitation, announced that they have entered into a license agreement pursuant to which HighLife has granted to Peijia an exclusive license regarding certain proprietary TMVR products currently in development by the Licensor. Under the Agreement, Peijia is entitled to, among other things, manufacture, develop, and commercialize the products in the greater China region, and HighLife is in return entitled to receive an upfront fee and subsequent milestone payments. ....

France General , Hong Kong , Yi Zhang , Nicolo Piazza , Global Expansion Of Highlife Technology , Prnewswire Peijia Medical Ltd Hk Stock Code , Peijia Medical , Mcgill University Health Centre , Corevalve Inc , Collaboration Strengthens Peijia , Largely Untapped Market , Supports Global Expansion , Medical Ltd , Mcgill University Health , Key Opinion Leader , Principal Investigator , License Agreement , Sofinnova Partners , Andera Partners , Medical Limited , Stock Exchange , Hong Kong Limited , Highlife Transeptal Mitral Valve , பிரான்ஸ் ஜநரல் , ஹாங் காங் , இ ஜாங் ,

Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China » Notizie italiane in tempo reale!


21 dicembre 2020
Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife’s Technology
SUZHOU, China and PARIS, Dec. 21, 2020 /PRNewswire/  Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a Paris-based medical device company, focused on the development of a unique transeptal mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced that they have entered into a license agreement pursuant to which HighLife has granted to Peijia an exclusive license regarding certain proprietary TMVR products currently in development by the Licensor. Under the Agreement, Peijia is entitled to, among other things, manufacture, develop, and commercialize the products in the greater China region, and HighLife is in return entitled to receive an upfront fee and subsequent milestone payments. ....

France General , Hong Kong , Yi Zhang , Nicolo Piazza , Global Expansion Of Highlife Technology , Peijia Medical Ltd Hk Stock Code , Peijia Medical , Mcgill University Health Centre , Strengthens Peijia , Largely Untapped Market , Supports Global Expansion , Peijia Medical Ltd , Mcgill University Health , Key Opinion Leader , Principal Investigator , License Agreement , Sofinnova Partners , Andera Partners , Medical Limited , Stock Exchange , Hong Kong Limited , Highlife Transeptal Mitral Valve , பிரான்ஸ் ஜநரல் , ஹாங் காங் , இ ஜாங் , நிகோலோ பியாஸ்ஸா ,